Literature DB >> 8141840

Variability in cholesterol content and physical properties of lipoproteins containing apolipoprotein B-100.

N Abate1, G L Vega, S M Grundy.   

Abstract

The primary objective of this study was to determine the variability in cholesterol carrying capacity of low density lipoproteins (LDLs) and other apolipoprotein B (apo B)-containing lipoproteins in normolipidemic men. One hundred and fifty-nine normolipidemic men, ages 21 to 73 years, were enrolled. In addition to determining plasma lipids and lipoproteins, three primary measurements were made: ratios of cholesterol to apo B in LDL; the electrophoretic pattern of LDL, i.e. pattern A, AB, or B; and levels of cholesterol in all lipoproteins other than high density lipoproteins (nonHDL-cholesterol) along with total apo B. First, the data revealed that about 85% of the variability of LDL-cholesterol levels can be accounted for by LDL-apo B levels, whereas the remaining 15% can be explained by differences in LDL-cholesterol/apo B ratios. Second, LDL electrophoretic pattern A was the predominant pattern in young adult men, but in older men the pattern shifted increasingly to AB and B. And third, there was a high correlation between nonHDL-cholesterol levels and total apo B levels, which suggests that nonHDL-cholesterol can be used as a relatively accurate surrogate for total apo B levels in normolipidemic individuals.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8141840     DOI: 10.1016/0021-9150(93)90187-y

Source DB:  PubMed          Journal:  Atherosclerosis        ISSN: 0021-9150            Impact factor:   5.162


  7 in total

Review 1.  Goals of statin therapy: three viewpoints.

Authors:  Gilbert R Thompson; Christopher J Packard; Neil J Stone
Journal:  Curr Atheroscler Rep       Date:  2002-01       Impact factor: 5.113

Review 2.  How do elevated triglycerides and low HDL-cholesterol affect inflammation and atherothrombosis?

Authors:  Francine K Welty
Journal:  Curr Cardiol Rep       Date:  2013-09       Impact factor: 2.931

3.  Joint role of non-HDL cholesterol and glycated haemoglobin in predicting future coronary heart disease events among women with type 2 diabetes.

Authors:  M B Schulze; I Shai; J E Manson; T Li; N Rifai; R Jiang; F B Hu
Journal:  Diabetologia       Date:  2004-12-15       Impact factor: 10.122

4.  Calcium-sensing receptor gene (CASR) polymorphisms and CASR transcript level concerning dyslipidemia in hemodialysis patients: a cross-sectional study.

Authors:  Alicja E Grzegorzewska; Bartosz A Frycz; Monika Świderska; Leszek Niepolski; Adrianna Mostowska; Paweł P Jagodziński
Journal:  BMC Nephrol       Date:  2019-11-27       Impact factor: 2.388

5.  Uncontrolled hypertension in patients with type 2 diabetes: What are the correlates?

Authors:  Soghra Rabizadeh; Bahareh Gholami; Shiva Mahmoudzadeh Kani; Armin Rajab; Hossein Farrokhpour; Alireza Esteghamati; Manouchehr Nakhjavani
Journal:  J Clin Hypertens (Greenwich)       Date:  2021-08-21       Impact factor: 3.738

Review 6.  Implications of the obesity epidemic for lipid-lowering therapy: non-HDL cholesterol should replace LDL cholesterol as the primary therapeutic target.

Authors:  Michel R Hoenig
Journal:  Vasc Health Risk Manag       Date:  2008

7.  Discordance of Low-Density Lipoprotein Cholestrol and Non-High-Density Lipoprotein Cholestrol and Coronary Artery Disease Severity.

Authors:  Ozge Kurmus; Aycan Fahri Erkan; Berkay Ekici; Turgay Aslan; Murat Eren
Journal:  Arq Bras Cardiol       Date:  2020-03       Impact factor: 2.000

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.